It is likely that because of the elimination of baseline ERK/MAPK activation noise, these CRC cells were more sensitive to subsequent EGF stimulation, and the ERK/MAPK signaling variation could have been detected with more sensitivity in our studies. The gene discussed is EGF; the disease is colorectal carcinoma.